Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 368-370

  Davis, Timothy M E ^b   Binh, Tran Quang ^a   Ilett, Kenneth F ^b   Batty, Kevin T ^b   Phuöng, Hoang Lan ^a   Chiswell, Gregory M ^b   Phuong, Vu Duong Bich ^a   Agus, Cindy ^b  

^a CHO RAY HOSPITAL   (Viet Nam)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; DIHYDROARTEMISININ;

ADOLESCENT; ADULT; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUMBAR PUNCTURE; MALARIA; MALARIA FALCIPARUM; MALE; MASS SPECTROMETRY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; SESQUITERPENES;

EID: 12244298238     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.368-370.2003     Document Type: Article

References (27)

1. Barradell, L. B., and A. Fitton. 1995. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50:714-741.
2. Batty, K. T., T. M. E. Davis, L. T. A. Thu, T. Q. Binh, T. K. Anh, and K. F. Ilett. 1986. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria. J. Chromatogr. B 677:345-350.
3. Batty, K. T., L. T. A. Thu, T. M. E. Davis, K. F. Ilett, T. X. Mai, N. C. Hung, N. P. Tien, S. M. Powell, H. V. Thein, T. Q. Binh, and N. V. Kim. 1998. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 45:123-129.
4. Brewer, T. G., S. J. Grate, J. O. Peggins, P. J. Weina, J. M. Petras, B. S. Levine, M. H. Heiffer, and B. G. Schuster. 1994. Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51:251-259.
5. Classen, W., B. Altmann, P. Gretener, C. Souppart, P. Skelton Stroud, and G. Krinke. 1999. Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs. Exp. Toxicol. Pathol. 51:507-516.
6. Davis, T. M. E., F. X. Breheny, P. A. Kendall, F. Daly, K. T. Batty, A. Singh, and K. F. Ilett. 1997. Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate. Med. J. Aust. 166:416-418.
7. Davis, T. M. E., H. L. Phuong, K. F. Ilett, N. C. Hung, K. T. Batty, V. D. B. Phuong, S. M. Powell, H. V. Thien, and T. Q. Binh. 2001. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob. Agents Chemother. 45:181-186.
8. Davis, T. M. E., Y. Suputtamongkol, J. Spencer, S. Ford, N. Chienkul, W. Schulenburg, and N. J. White. 1992. Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin. Infect. Dis. 15:256-266.
9. Dayan, A. D. 1998. Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use? Med. Trop. (Mars) 58:32-37.
10. Elias, Z., E. Bonnet, B. Marchou, and P. Massip. 1999. Neurotoxicity of artemisinin: possible counseling and treatment of side effects. Clin. Infect. Dis. 28:1330-1331.
11. Genovese, R. F., D. B. Newman, J. M. Petras, and T. G. Brewer. 1998. Behavioral and neural toxicity of arteether in rats. Pharmacol. Biochem. Behav. 60:449-458.
12. Hien, T. T., N. P. J. Day, H. P. Nguyen, T. H. Nguyen, T. H. Tran, P. L. Pham, X. S. Dinh, V. C. Ly, V. Ha, D. Waller, T. E. Peto, and N. J. White. 1996. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N. Engl. J. Med. 335:76-83.
13. Kearney, B. P., and F. T. Aweeka. 1999. The penetration of anti-infectives into the central nervous system. Neurol. Clin. N. Am. 17:883-900.
14. Miller, L. G., and C. B. Panosian. 1997. Ataxia and slurred speech after artesunate treatment for falciparum malaria. N. Engl. J. Med. 336:1328.
15. Mohamed, S. S., S. A. Khalid, S. A. Ward, T. S. Wan, H. P. Tang, M. Zheng, R. K. Haynes, and G. Edwards. 1999. Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring. J. Chromatogr. B 731:251-260.
16. Murphy, S., E. Mberu, D. Muhia, M. English, J. Crawley, C. Waruiru, B. Lowe, C. Newton, P. Winstanley, K. Marsh, and W. Watkins. 1997. The disposition of intramuscular artemether in children with cerebral malaria: a preliminary study. Trans. R. Soc. Trop. Med. Hyg. 91:331-334.
17. Nui, X. Y., L. Y. Ho, Z. H. Ren, and Z. Y. Song. 1985. Metabolic fate of qinghaosu in rats: a new TLC densitometric method for its determination in biological material. Eur. J. Drug Metab. Pharmacokinet. 10:55-59.
18. Petras, J. M., D. E. Kyle, M. Gettayacamin, G. D. Young, R. A. Bauman, H. K. Webster, K. D. Corcoran, J. O. Peggins, M. A. Vane, and T. G. Brewer. 1997. Arteether: risks of two-week administration in Macaca mulatta. Am. J. Trop. Med. Hyg. 56:390-396.
19. Rao, V. V., J. L. Dahlheimer, M. E. Bardgett, A. Z. Snyder, R. A. Finch, A. C. Sartorelli, and D. Piwnica-Worms. 1999. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA 96:3900-3905.
20. Scheld, W. M. 1989. Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. Rev. Infect. Dis. 11:S1669-S1690.
21. Smith, S. L., C. J. Sadler, C. C. Dodd, G. Edwards, S. A. Ward, B. K. Park, and W. G. McLean. 2001. The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro. Biochem. Pharmacol. 61:409-416.
22. Svensson, U. S., R. Sandstrom, O. Carlborg, H. Lennernas, and M. Ashton. 1999. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab. Dispos. 27:227-232.
23. Van-Hensbroek, M. B., E. Onyiorah, S. Jaffar, G. Schneider, A. Palmer, J. Frenkel, G. Enwere, S. Forsk, A. Nusmeijer, S. Bennett, B. Greenwood, and D. Kwiatkowski. 1996. A trial of artemether or quinine in children with cerebral malaria. N. Engl. J. Med. 335:69-75.
24. Van Vugt, M., B. J. Angus, R. N. Price, C. Mann, J. A. Simpson, C. Poletto, S. E. Htoo, S. Looareesuwan, N. J. White, and F. Nosten. 2000. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 62:65-69.
25. Warrell, D. A., M. Molyneux, and P. Beales. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):1-69.
26. White, N. J., and S. Looareesuwan. 1989. Cerebral malaria, p. 118-143. In G. T. Strickland (ed.), Infections of the nervous system. Saunders, London, England.
27. Wijnholds, J., E. C. de Lange, G. L. Scheffer, D. J. van den Berg, C. A. Mol, M. van der Valk, A. H. Schinkel, R. J. Scheper, D. D. Breimer, and P. Borst. 2000, Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Investig. 105:279-285.